Change of CGRP Plasma Concentrations in Migraine after Discontinuation of CGRP-(Receptor) Monoclonal Antibodies

Discontinuation of treatment with monoclonal antibodies (mAb) targeting the Calcitonin Gene-Related Peptide (CGRP) pathway leads to an increase in migraine frequency. We aimed to assess changes in free and total CGRP plasma concentrations after the discontinuation of CGRP(-receptor) mAbs. This prosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Raffaelli, Bianca, Terhart, Maria, Fitzek, Mira Pauline, Lange, Kristin Sophie, Mecklenburg, Jasper, Overeem, Lucas Hendrik, Siebert, Anke, Storch, Elisabeth, Reuter, Uwe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861447/
https://www.ncbi.nlm.nih.gov/pubmed/36678920
http://dx.doi.org/10.3390/pharmaceutics15010293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861447/
https://www.ncbi.nlm.nih.gov/pubmed/36678920
http://dx.doi.org/10.3390/pharmaceutics15010293

Ejemplares similares